Decidualization of uterine adenomyoma in a pregnant woman: a case report with immunohistochemical study

Affiliation auteurs!!!! Error affiliation !!!!
TitreDecidualization of uterine adenomyoma in a pregnant woman: a case report with immunohistochemical study
Type de publicationJournal Article
Year of Publication2015
AuteursTerada T
JournalARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume291
Pagination399-402
Date PublishedFEB
Type of ArticleArticle
ISSN0932-0067
Mots-clésAdenomyoma, Decidualization, Immunohistopathology, Pregnancy, uterus
Résumé

Decidualization of uterine adenomyoma has not been reported, to the best of the author's knowledge. To report a case of uterine adenomyoma with decidualization. A 43-year-old pregnant woman with ``myoma'' underwent cesarean operation and ``myomectomy'' at 37 gestation weeks. The operation was successful, and the baby and mother were healthy. Grossly, the ``myoma'' measured 12 x 10 x 10 cm, and the consistency was firm. Microscopically, the tumor was adenomyoma consisting of smooth muscle bundles and endometrial islands. Characteristically, the endometrial stroma showed marked decidualization. An immunohistochemical study showed that the decidual cells were positive for pancytokeratin AE1/3, pancytokeratin CAM5.2, cytokeratin (CK)7, CK18, vimentin, CA125, CD10, estrogen receptor (ER), progesterone receptor (PgR), and Ki-67 (labeling 1 %). They were negative for CK34 beta E12, CK5/6, CK8, CK14, CK19, CK20, EMA, p63, desmin, alpha-smooth muscle actin, S100 protein, CK34, CD68, and p53. These results show that marked decidualization occurs in adenomyoma during pregnancy, and that the decidual cells are positive for pancytokeratin AE1/3, pancytokeratin CAM5.2, CK7, CK18, vimentin, CA125, CD10, ER, and PgR. A rare case of uterine adenomyoma with decidualization is reported.

DOI10.1007/s00404-014-3413-3